TME at the Annual Meeting
Read about the AACR Virtual Sessions in April and June 2020!
Due to the escalation of the COVID-19 pandemic, the AACR Leadership has made the decision not to move forward with an on-site Annual Meeting 2020. However, as indicated previously, many exciting AM 2020 “virtual” sessions are programmed to take place on April 27-28 and June 22-24, 2020. The schedule for these “virtual” sessions will be posted on the AACR Annual Meeting 2020 website, that also provides information on refunds of all paid registration fees for the on-site Meeting. We look forward to your participation in these virtual sessions!
See below for original program of TME events at the on-site AACR Annual Meeting 2020
The Annual Meeting is an extraordinary venue that fosters scientific discussions and helps build bridges across various disciplines. We encourage all meeting attendees to take advantage of the opportunities presented at the meeting to learn about the latest breakthroughs in the tumor microenvironment, attend sessions outside your own areas of expertise and network with other scientists and clinicians interested in all areas of cancer research.
The AACR Annual Meeting 2020 will be held in San Diego, California, April 24-29, 2020.
These TME events are scheduled during the Annual Meeting:
Systemic effects of the tumor microenvironment
Sunday, April 26, 2020, 6 – 8 p.m.
San Diego Convention Center
Upper Level, Room 11 A-B
Sheila A. Stewart, DPhil, Washington University in St. Louis, St. Louis, Missouri (TME chairperson 2019-2020)
Theresa A. Guise, MD, Indiana University School of Medicine, Indianapolis, Indiana (TME chairperson 2020-2021)
Kurt Weiss, MD, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and
Rebecca Watters, PhD, University of Pittsburgh, Pittsburgh, Pennsylvania
Advocacy and Cancer Research in Pittsburgh: Building Bridges Between Patients and Scientists
Swarnali Acharyya, PhD, Columbia University, New York, New York
Systemic effects of metastasis: impact on skeletal muscle
Xiang (Shawn) Zhang, PhD, Baylor University College of Medicine, Houston, Texas
One microenvironment does not fit all: intertumoral variability of systemic effects and its impact on immunotherapies
Presentations by Early-career Investigators (highly-rated abstracts):
Stromal and immune changes in the aged lung microenvironment create a permissive niche for the metastatic outgrowth of melanoma
Mitchell Fane, PhD, Postdoctoral Fellow, Johns Hopkins University School of Public Health, Baltimore, Maryland
Lineage tracing and Wnt dependence of ectopic crypt stem/progenitor cells in a mouse model of Hereditary Mixed Polyposis Syndrome
Ester Gil Vazquez, MS, Wellcome Center for Human Genetics, University of Oxford, United Kingdom
Integration of tissue-engineered models of prostate cancer bone metastasis with intravital imaging and computational modeling reveals Radium 223 zonal cytotoxicity
Eleonora Dondossola, PhD, Instructor, GU Medical Oncology, UT MD Anderson Cancer Center, Houston, Texas
A multi-omic single cell and spatial atlas of breast cancer reveals
stromal suppression of anti-cancer immunity
Alexander Swarbrick, PhD, Laboratory Head, Tumour Progression / Cancer Division, Garvan Institute of Medical Research, Darlinghurst, Australia
Joint Cancer Immunology (CIMM) / Tumor Microenvironment (TME) Working Groups Evening Scientific Session
TME sculpting of the immune response: How do we leverage it to kill tumor cells?
Monday, April 27, 2020; 6:30 – 8:30 p.m.
San Diego Convention Center
Upper Level, Room 5 A-B
The chairpersons of the Cancer Immunology (CIMM) and the Tumor Microenvironment (TME) Working Groups jointly organize a stimulating program so that all attendees can benefit by the perspective of leaders in the field.
Weiping Zou, MD, PhD, University of Michigan School of Medicine, Ann Arbor, Michigan (CIMM chairperson)
Sheila A. Stewart, DPhil, Washington University in St. Louis, St. Louis, Missouri (TME chairperson)
Douglas T. Fearon, MD, Cold Spring Harbor Laboratory/Weill Cornell Medical College, Cold Spring Harbor, New York
Transglutaminase-2 assembles a CXCL12-coat on pancreatic cancer cells to resist immune attack
Costas A. Lyssiotis, PhD, University of Michigan, Ann Arbor, Michigan
Metabolic Networks in the Tumor Microenvironment
Ellen Puré, PhD, University of Pennsylvania School of Veterinary Medicine, Penn Vet Cancer Center, Philadelphia, Pennsylvania
Impact of Fibroblast Activation Protein on Metastasis
Ruth Scherz-Shouval, PhD, Weizmann Institute of Science, Rehovot, Israel
Transcriptional heterogeneity in breast cancer associated fibroblasts
For TME-related sessions, visit the TME-specific online planner when available. Please note that the list may not be all-inclusive of the TME-related sessions offered.
For all AACR Annual Meeting 2020 sessions, see the Annual Meeting 2020 online planner when available. Also, visit the AACR Annual Meeting 2020 homepage for more logistical information.
Additionally, remember to check the Cancer Immunology Working Group webpage for other sessions of interest.